Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coenzyme Q10 (nanoQuinon) in Progressive Supranuclear Palsy
NCT00328874Phase 2Completed
- Sponsor
- German Parkinson Study Group
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of coenzyme q10 in progressive supranuclear palsy (PSP), sponsored by German Parkinson Study Group. Started May 2006; status: completed.
02
Drugs
coenzyme q10
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT00328874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00328874.